Retail sale of pharmaceutical products
RINGEN BANDAGIST AS
Revenue 2024
NOK 22.8m
Operating profit
NOK 1.3m
Equity
NOK 419,000
Incorporated
2010
Share capital
NOK 100,000
Key figures · 2024
Current ratio
1.16
Equity ratio
9.6%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 5.5% | |
| Net margin (%%) | 4.2% | |
| Return on assets (%%) | 29.0% | |
| Likviditet | ||
| Current ratio | 1.16 | |
| Working capital | 579k | |
| Soliditet | ||
| Equity ratio (%%) | 9.6% | |
| Debt-to-equity ratio | 9.38 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.